Related Experiment Video
Updated: Mar 17, 2026

08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
13.9K
Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
Mahmood A Hamed1,2, Seiichi Nakata1, Ramadan H Sayed2
1Department of Otolaryngology, Second Hospital, Fujita Health University School of Medicine, Nagoya, Japan.
Clinical and Experimental Otorhinolaryngology
|July 22, 2016
Summary
Acquired cholesteatoma causes bone resorption in the temporal bone, leading to serious complications. Future research should focus on non-surgical treatments and predictors of cholesteatoma aggressiveness.
Area of Science:
- Otolaryngology
- Pathophysiology
- Biomolecular Research
Background:
- Cholesteatoma is a non-tumorous lesion of the temporal bone with destructive bone resorption capabilities.
- The exact pathogenesis and bone resorption mechanisms of acquired cholesteatoma remain incompletely understood.
- Existing theories on cholesteatoma aetiopathogenesis are debated among otolaryngologists.
Approach:
- Comprehensive review of Medline/PubMed literature on acquired cholesteatoma pathogenesis and bone resorption.
- Keywords used include 'aetiopathogenesis, bone resorption, acquired cholesteatoma, temporal bone, and cytokines'.
- Reference lists of identified reviews were also searched to strengthen the study.
Key Points:
- Acquired cholesteatoma causes significant bone resorption in the temporal bone, potentially leading to fatal complications.
- Biomolecular research has advanced understanding of cholesteatoma pathophysiology and its bone-destructive mechanisms.
- Surgery remains the primary treatment, but the mechanism of bone resorption requires further clarification.
Conclusions:
- Future research should prioritize non-surgical therapeutic options, including anti-growth, anti-proliferative, and apoptotic agents.
- Developing medications that antagonize osteoclastogenesis is crucial for new treatment strategies.
- Identifying predictors of cholesteatoma aggressiveness can optimize intervention timing and prevent complications.
Related Concept Videos
Osteoclasts in Bone Remodeling
4.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
Bone Remodeling
40.9K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.9K
Bone Formation by Endochondral Ossification
11.7K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
11.7K
Growth of Cartilage and Bone Tissue
4.6K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.6K
Bone Disorders
6.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.0K
Chronic Pancreatitis I: Introduction
848
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
848

